Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1936 1
1940 1
1947 1
1949 1
1954 1
1955 2
1957 5
1958 1
1959 3
1960 1
1961 1
1962 4
1963 1
1964 5
1965 2
1966 3
1967 2
1968 1
1969 4
1970 4
1971 4
1972 8
1973 7
1974 6
1975 7
1976 3
1977 8
1978 8
1979 14
1980 16
1981 5
1982 10
1983 21
1984 18
1985 23
1986 21
1987 32
1988 24
1989 34
1990 29
1991 28
1992 26
1993 38
1994 37
1995 30
1996 44
1997 45
1998 44
1999 68
2000 62
2001 100
2002 120
2003 142
2004 174
2005 268
2006 311
2007 307
2008 383
2009 388
2010 494
2011 601
2012 639
2013 741
2014 838
2015 998
2016 1072
2017 1165
2018 1406
2019 1618
2020 1741
2021 2029
2022 2421
2023 2182
2024 2461
2025 2411
2026 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23,010 results

Results by year

Filters applied: . Clear all
Page 1
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer.
Meylan M, Petitprez F, Becht E, Bougoüin A, Pupier G, Calvez A, Giglioli I, Verkarre V, Lacroix G, Verneau J, Sun CM, Laurent-Puig P, Vano YA, Elaïdi R, Méjean A, Sanchez-Salas R, Barret E, Cathelineau X, Oudard S, Reynaud CA, de Reyniès A, Sautès-Fridman C, Fridman WH. Meylan M, et al. Among authors: sun cm. Immunity. 2022 Mar 8;55(3):527-541.e5. doi: 10.1016/j.immuni.2022.02.001. Epub 2022 Feb 28. Immunity. 2022. PMID: 35231421 Free article.
Targeting ADAR1 with a small molecule for the treatment of prostate cancer.
Wang X, Li J, Zhu Y, Shen H, Ding J, Zeng T, Min W, Liang SQ, Huang L, Shi Z, Shen H, Huang F, Yuan K, Kuang W, Ji M, Sun C, Hou Y, Wang L, Chen W, Jiang Y, Hao H, Xiao Y, Yang P. Wang X, et al. Among authors: sun c. Nat Cancer. 2025 Mar;6(3):474-492. doi: 10.1038/s43018-025-00907-4. Epub 2025 Feb 10. Nat Cancer. 2025. PMID: 39930013
International experts consensus guidelines on robotic liver resection in 2023.
Liu R, Abu Hilal M, Wakabayashi G, Han HS, Palanivelu C, Boggi U, Hackert T, Kim HJ, Wang XY, Hu MG, Choi GH, Panaro F, He J, Efanov M, Yin XY, Croner RS, Fong YM, Zhu JY, Wu Z, Sun CD, Lee JH, Marino MV, Ganpati IS, Zhu P, Wang ZZ, Yang KH, Fan J, Chen XP, Lau WY. Liu R, et al. Among authors: sun cd. World J Gastroenterol. 2023 Aug 28;29(32):4815-4830. doi: 10.3748/wjg.v29.i32.4815. World J Gastroenterol. 2023. PMID: 37701136 Free PMC article. Review.
LDLRAD3 is a receptor for Venezuelan equine encephalitis virus.
Ma H, Kim AS, Kafai NM, Earnest JT, Shah AP, Case JB, Basore K, Gilliland TC, Sun C, Nelson CA, Thackray LB, Klimstra WB, Fremont DH, Diamond MS. Ma H, et al. Among authors: sun c. Nature. 2020 Dec;588(7837):308-314. doi: 10.1038/s41586-020-2915-3. Epub 2020 Nov 18. Nature. 2020. PMID: 33208938 Free PMC article.
Quantum Reliability.
Cui LX, Du YM, Sun CP. Cui LX, et al. Among authors: sun cp. Phys Rev Lett. 2023 Oct 20;131(16):160203. doi: 10.1103/PhysRevLett.131.160203. Phys Rev Lett. 2023. PMID: 37925693
A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV.
Sun C, Kang YF, Fang XY, Liu YN, Bu GL, Wang AJ, Li Y, Zhu QY, Zhang H, Xie C, Kong XW, Peng YJ, Lin WJ, Zhou L, Chen XC, Lu ZZ, Xu HQ, Hong DC, Zhang X, Zhong L, Feng GK, Zeng YX, Xu M, Zhong Q, Liu Z, Zeng MS. Sun C, et al. Cell Host Microbe. 2023 Nov 8;31(11):1882-1897.e10. doi: 10.1016/j.chom.2023.09.011. Epub 2023 Oct 16. Cell Host Microbe. 2023. PMID: 37848029 Free article.
CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1.
Miao B, Hu Z, Mezzadra R, Hoeijmakers L, Fauster A, Du S, Yang Z, Sator-Schmitt M, Engel H, Li X, Broderick C, Jin G, Gomez-Eerland R, Rozeman L, Lei X, Matsuo H, Yang C, Hofland I, Peters D, Broeks A, Laport E, Fitz A, Zhao X, Mahmoud MAA, Ma X, Sander S, Liu HK, Cui G, Gan Y, Wu W, Xiao Y, Heck AJR, Guan W, Lowe SW, Horlings HM, Wang C, Brummelkamp TR, Blank CU, Schumacher TNM, Sun C. Miao B, et al. Among authors: sun c. Cancer Cell. 2023 Oct 9;41(10):1817-1828.e9. doi: 10.1016/j.ccell.2023.08.008. Epub 2023 Sep 7. Cancer Cell. 2023. PMID: 37683639 Free PMC article.
23,010 results
You have reached the last available page of results. Please see the User Guide for more information.